{
    "root": "30c946d7-a6ce-e383-e063-6394a90a773e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Escitalopram",
    "value": "20250320",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "ESCITALOPRAM OXALATE",
            "code": "5U85DBW7LO"
        }
    ],
    "indications": "escitalopram selective serotonin reuptake inhibitor ( ssri ) indicated : treatment major depressive disorder ( mdd ) adults pediatric patients 12 years age older ( 1 ) treatment generalized anxiety disorder ( gad ) adults ( 1 )",
    "contraindications": "indication population recommended dose mdd adults ( 2.1 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily mdd pediatric patients 12 years older ( 2.1 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily gad adults ( 2.2 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily additional benefits seen 20 mg daily ( 2.1 ) . administer daily , morning evening , without food ( 2.3 ) elderly patients : recommended 10 mg daily ( 2.4 ) hepatic impairment : recommended 10 mg daily ( 2.4 , 8.6 ) discontinuing escitalopram tablets , reduce dose gradually whenever possible ( 2.5 )",
    "warningsAndPrecautions": "supplied escitalopram tablets , usp , 5 mg round , white off-white , biconvex , film coated tablets , debossed “ p 5 ” one side plain side . supplied : unit dose packages 100 ( 10 x 10 ) ndc 60687-865-01 storage handling store 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) . protection : blister torn broken .",
    "adverseReactions": "escitalopram tablets contraindicated patients : taking maois escitalopram tablets within 14 days stopping treatment escitalopram tablets increased risk serotonin syndrome . escitalopram tablets within 14 days stopping maoi intended treat psychiatric disorders also contraindicated [ ( 2.7 ) ( 5.2 ) ] . starting escitalopram tablets patient treated maois linezolid intravenous methylene blue also contraindicated increased risk serotonin syndrome [ ( 2.6 ) ( 5.2 ) ] . taking pimozide [ ( 7 ) ] . hypersensitivity escitalopram citalopram inactive ingredients escitalopram tablets .",
    "indications_original": "Escitalopram is a selective serotonin reuptake inhibitor (SSRI) indicated for the: treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older ( 1 ) treatment of generalized anxiety disorder (GAD) in adults ( 1 )",
    "contraindications_original": "Indication and Population Recommended Dose MDD in Adults ( 2.1 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily MDD in Pediatric Patients 12 years and older ( 2.1 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily GAD in Adults ( 2.2 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily No additional benefits were seen at 20 mg once daily ( 2.1 ). Administer once daily, morning or evening, with or without food ( 2.3 ) Elderly patients: recommended dosage is 10 mg once daily ( 2.4 ) Hepatic impairment: recommended dosage is 10 mg once daily ( 2.4 , 8.6 ) When discontinuing escitalopram tablets, reduce dose gradually whenever possible ( 2.5 )",
    "warningsAndPrecautions_original": "How Supplied\n                     \n                     Escitalopram Tablets, USP, 5 mg are round, white to off-white, biconvex, film coated tablets, debossed with “P 5” on one side and plain on the other side. They are supplied in:\n \n                  Unit dose packages of 100 (10 x 10) NDC 60687-865-01\n                  \n                     Storage and Handling\n                     \nStore at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).\n \n                  \n                     FOR YOUR PROTECTION: Do not use if blister is torn or broken.",
    "adverseReactions_original": "Escitalopram tablets are contraindicated in patients:\n                  \n                     taking MAOIs with escitalopram tablets or within 14 days of stopping treatment with escitalopram tablets because of an increased risk of serotonin syndrome. The use of escitalopram tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated \n   [see\n                        \n                           Dosage and Administration (2.7)\n                        \n                        and\n                        \n                           Warnings and Precautions (5.2)\n                        \n                        ]. Starting escitalopram tablets in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome \n   [see\n                        \n                           Dosage and Administration (2.6)\n                        \n                        and\n                        \n                           Warnings and Precautions(5.2)\n                        \n                        ].\n  \n                     taking pimozide \n   [see\n                        \n                           Drug Interactions (7)\n                        \n                        ].\n  \n                     with a hypersensitivity to escitalopram or citalopram or any of the inactive ingredients in escitalopram tablets."
}